QUASAR2_2B | R Documentation |
Kaplan-Meier digitized data from QUASAR2, figure 2B (PMID 27660192). A reported sample size of 1,952 for a primary endpoint of DFS3 in colorectal cancer.
QUASAR2_2B
A data frame of 1,939 observations and 3 variables:
time | event time (in years) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (cap, cap_bev) | |
Kerr RS, Love S, Segelov E, et al. Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. Lancet Oncol 2016; 17: 1543–57.
summary(QUASAR2_2B)
kmplot(QUASAR2_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.